Nycomed launches COPD drug Daxas in Germany – Pharma Times
Nycomed launches COPD drug Daxas in Germany Pharma Times The drug is indicated for maintenance treatment of severe COPD associated with chronic bronchitis in adults with a history of frequent exacerbations as an ... Nycomed: Daxas launches in Germany but limited indication restricts potentialTrading Markets (press release) Nycomed kicks off global market launch of new COPD drug Daxas in GermanyThe Pharma Letter all 3 news articles » |